ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "KL-50 in post TMZ MMR-deficient GBM"
Episode Synopsis
Dr. Iyad Alnahhas interviews Dr. Craig Horbinski about his and his team's recent manuscript entitled "The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma", published online in Neuro-Oncology in December 2024.
More episodes of the podcast Neuro-Oncology: The Podcast
A transcriptomic atlas of CNS tumors
11/07/2025
Gut microbiome in primary CNS lymphoma
27/06/2025
Germline analysis of diffuse midline glioma
08/06/2025
Radio-Pathomic maps and MR perfusion
18/04/2025
CSF proteomics in glioma
21/03/2025
Vorasidenib in IDH mutant glioma
08/03/2025
In God we trust